Redmile Group’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Redmile Group’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-298,800	Closed	-$11.2M	–	90
2018 Q1	$11.2M	Buy	+298,800	New	+$12.6M	0.43%	48

Redmile Group's ARMO Position: Q2 2018 in Review

Redmile Group sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 298,800 shares — an estimated $11.2M sold.

Redmile Group first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $11.2M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Redmile Group reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Redmile Group sold 298,800 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $11.2M.
Redmile Group first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Redmile Group's ARMO BioSciences, Inc. Common Stock position peaked at $11.2M in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Redmile Group's 13F filing for Q2 2018, filed 14 Aug 2018.